ClearPoint Neuro (CLPT) Intangibles (2012 - 2026)

ClearPoint Neuro (CLPT) posted Intangibles of $13.4 million for Q1 2026, down 3.61% sequentially from $13.9 million in Q4 2025.

ClearPoint Neuro (CLPT) Intangibles (2012 - 2026) Analysis & Trends

ClearPoint Neuro has reported Intangibles for 5 years, with the latest figure at $13.4 million in Q1 2026.

Quarterly Intangibles changed N/A year-over-year to $13.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.4 million (changed N/A YoY) and the FY2025 annual result came in at $13.9 million, changed N/A from the prior year.
Intangibles slipped to $13.4 million in Q1 2026 per CLPT's latest filing, from $13.9 million in the prior quarter.
Over five years, Intangibles peaked at $13.9 million in Q4 2025 and troughed at $13.4 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Intangibles (Qtr)
1	Abbott Laboratories	199.49 Bn	193.88 Bn	7.27 Bn	17.21 Bn
2	Stryker	127.80 Bn	124.32 Bn	4.50 Bn	5.74 Bn
3	Medtronic	118.98 Bn	109.76 Bn	6.41 Bn	10.15 Bn
4	Boston Scientific	73.58 Bn	73.04 Bn	3.85 Bn	6.92 Bn
5	Edwards Lifesciences	51.93 Bn	47.68 Bn	1.35 Bn	1.38 Bn
6	Dexcom	34.34 Bn	32.39 Bn	830.00 Mn	101.60 Mn
7	GE HealthCare Technologies	33.76 Bn	31.66 Bn	2.18 Bn	1.89 Bn
8	Koninklijke Philips	26.37 Bn	23.05 Bn	4.55 Bn	2.98 Bn
9	Steris	23.07 Bn	22.59 Bn	684.20 Mn	1.56 Bn
10	ClearPoint Neuro	465.92 Mn	436.52 Mn	6.71 Mn	12.92 Mn

Download Data